Squamous Cell Carcinoma Transformation from EGFR-mutated Lung Adenocarcinoma: A Case Report and Literature Review

Clin Lung Cancer. 2018 Jan;19(1):e63-e66. doi: 10.1016/j.cllc.2017.10.005. Epub 2017 Oct 19.

¹ Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Japan; Department of Respiratory Medicine, Tottori Prefectural Central Hospital, Tottori, Japan. Electronic address: hiroizu0211@gmail.com.
² Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Japan.
³ Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University, Yonago, Japan; Department of Respiratory Medicine, Tottori Prefectural Central Hospital, Tottori, Japan.
⁴ Department of Thoracic and Cardiovascular Surgery, Tottori Prefectural Central Hospital, Tottori, Japan.
⁵ Department of Pathology, Tottori Prefectural Central Hospital, Tottori, Japan.

No abstract available

Keywords: Acquired resistance; Histologic transformation; Non–small-cell lung cancer; Osimertinib; T790M.

Publication types